|
|
Kingsfordweg 151 1043 GR Amsterdam, The Netherlands phone:+31 (0)20 491 9601 fax:+31 (0)20 491 9090
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.spepharm.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Specialty pharmaceutical company dedicated to specialist and hospital drugs. |
 |
| Management |
| Jean-Franois Labb, Managing Director and Chief Executive Officer; Hans Vos, Chief Financial Officer; Neil L. Brown, Chief Business Officer; Caroline Dumas, Chief Medical Officer; Antoine Aulanier, VP Sales and Marketing |
| |
|
|
| |
|
| Keywords |
| pharmaceutical, oral mucositis, malignant hyperthermia, dry mouth |
|
|
|
| Description |
|
SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market.
Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care.
SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe.
The vision of SpePharm is to become a leading specialty pharma company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. |
 |
| Technology / Differentiation |
| Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care.
SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe.
The vision of SpePharm is to become a leading specialty pharma company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. |
 |
 |
|
|
|
|
|
|